Home » Topics » BioWorld Science

BioWorld Science
RSS

Enrollment ongoing in phase II study of ciprofloxacin/celecoxib fixed-dose combination

Nov. 29, 2019

KY-1043 demonstrates potent antitumor activity in vitro and in vivo

Nov. 29, 2019

Roche presents phase III data for atezolizumab plus bevacizumab in HCC

Nov. 29, 2019

G. mellonella as a promising in vivo model for assessing the pathogenesis of GBS

Nov. 29, 2019

TIFA as a new predictive biomarker of PAH

Nov. 29, 2019

New analgesic target and lead compound identified in rodents

Nov. 29, 2019

DP-13 begins phase II trial in primary aldosteronism

Nov. 29, 2019

OBI Pharma opens enrollment in phase I/II study of OBI-999 in advanced solid tumors

Nov. 29, 2019

KM Biologics presents dengue vaccine tested in monkeys

Nov. 29, 2019

Roche initiates first-in-human study of RO-7247669

Nov. 29, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
Alzheimer’s, beyond the brain
BioWorld
Researchers at Daping Hospital in China have reported that liver-targeted delivery of the APOE3-Christchurch (APOE3Ch) variant, a rare protective form of...
First cruise ship hantavirus genome points to zoonotic spillover
BioWorld
The initial appraisal of the first complete genome sequence of a hantavirus isolated from a patient in Switzerland who was a passenger on the cruise ship MV...
APAC monitors hantavirus as Singapore isolates 2 from cruise ship
BioWorld
Singapore’s Communicable Diseases Agency on May 7 said that it isolated two residents for hantavirus testing after the individuals disembarked from an Atlantic...